The tumor suppressor p53 is a transcription factor which binds DNA through a structurally complex domain stabilized by a zinc atom. Zinc chelation disrupts the architecture of this domain, inducing the protein to adopt an immunological phenotype identical to that of many mutant forms of p53. In this report, we used 65 Zn to show that incorporation of zinc within the protein was required for folding in the`wild-type' conformation capable of speci®c DNA-binding. Using a cellular assay, we show that addition of extracellular zinc at concentrations within the physiological range (5 mM) was required for renaturation and reactivation of wild-type p53. 
Introduction
The p53 protein is a zinc-binding transcription factor encoded by the tumor suppressor gene TP53, which is constitutively expressed in a latent form in most cells and tissues (reviewed in Gottlieb and Oren, 1998; Hainaut and Holstein, 2000; Janus et al., 1999) . Under exposure to various forms of genotoxic and nongenotoxic stress, p53 is activated and coordinates several anti-proliferative pathways to permanently delete cells containing damaged DNA from the pool of actively proliferating cells (Di Leonardo et al., 1994; Linke et al., 1997) . Induction of p53 in response to stress occurs essentially by post-translational modi®ca-tions resulting in protein stabilization (by escape from proteasome-mediated degradation) and in conformational changes that increase the anity of the protein for speci®c DNA sequences. This active form of p53 regulates the transcription of target genes or interacts with heterologous factors to mediate negative regulation of cell-cycle progression and induction of apoptosis. Cell-cycle arrest is controlled essentially by transcriptional modulation of p53-transactivated genes such as WAF-1 (a cyclin kinase inhibitor acting in both G1 and G2 phases) (El-Deiry et al., 1993) , GADD45 (a growth arrest and DNA damage response factor involved in a G2/M checkpoint) (Wang et al., 1999) and 14-3-3s (a signal transduction factor that inhibits G2/M progression) (Hermeking et al., 1997) . Induction of apoptosis involves both transcription-dependent and independent mechanisms. Pro-apoptotic transcriptional targets of p53 include BAX-1 (a regulator of mitochondrial permeability) Selvakumaran et al., 1994) , PIG-3 (a quinone oxidase homologue that may control the production of reactive oxygen species) , and APO1/CD95/ Fas and KILLER/DR5 (two members of the death receptor family) (Owen-Schaub et al., 1995; Wu et al., 1997) . Non-transcriptional mechanisms of apoptosis are thought to involve protein interactions between a multi-functional, regulatory domain in the C-terminus of p53 and the DNA helicases XPB and XPD in the TFIIH complex (Wang et al., 1996) .
Most of the TP53 gene mutations in cancer are missense mutations scattered in the region of the gene that encodes the sequence-speci®c DNA-binding domain (residues 102 ± 296), underlying the importance of this domain in the suppressive activity of p53. The structure of this domain has been elucidated by X-ray crystallography (as a complex between p53 and target DNA) (Cho et al., 1994) . This domain is made of an array of two beta-sheets supporting¯exible loop/helix structures that are in direct contact with the minor and major groove of a DNA consensus motif made of two inverted repeats of the motif RRRC(A/T). These loops are bridged together by the tetrahedral co-ordination of zinc on three cysteines (residues 176, 238 and 242) and one histidine (residue 179) (Cho et al., 1994) . This structure is¯exible, as illustrated by the existence of temperature-sensitive mutants that are able to switch between alternative conformations of the DNA-binding domain (see review in Milner, 1995) . Primary structure data suggest that this metal-dependent structure is conserved in the p53 homologues p73 and p63 (Kaelin, 1998) . Treatment of wild-type p53 with metal chelators in vitro induces the removal of zinc and oxidation of several important cysteines in the DNA-binding domain. This results in the disruption of the tertiary structure, with loss of DNA binding-activity and exposure of linear epitopes that are cryptic in the fully folded protein (such as the epitope recognized by the monoclonal antibody PAb240) (Fojta et al., 1999; Hainaut and Milner, 1993a,b; Pavletich et al., 1993) . These observations imply that metal binding is structurally important but so far there is little direct evidence that metal exchange plays a role in the regulation of the conformational¯exibility of the p53 protein.
Using a cell-permeant metal chelator, we have recently found that depletion of intracellular zinc could induce a change in p53 protein conformation, with loss of DNA-binding capacity, that was reversible upon removal of the chelator from the culture medium (Verhaegh et al., 1998) . We have also shown that metal ions competing with zinc, such as cadmium, inactivate p53 function in intact cells by inducing the protein to switch to a`mutant-like' conformation . These data suggest that changes in intracellular metal levels may aect p53 conformation, and that the zinc-binding structure in the protein may serve as a sensor for metal levels within the cell (reviewed in Meplan et al., 2000) .
In this report, we demonstrate for the ®rst time that folding of p53 in a DNA-binding conformation requires incorporation of zinc in vitro. Using cells exposed to the cell-permeant zinc chelator TPEN (N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine), we have developed a p53 renaturation assay to show that addition of zinc to the culture medium was required for p53 to fold into wild-type conformation. In addition to zinc, renaturation of p53 was observed with cobalt but not with copper, nickel, iron or cadmium, indicating that the geometry of the metal coordination and the size of the metal ion determine the correct folding of the protein.
Furthermore, we show that metallothionein (MT), a class of cysteine-rich, metal binding proteins that controls the intracellular distribution of zinc, acts as a potent chelator to remove zinc from p53 in vitro and modulates p53 transcriptional activity in intact cells.
Results
Incorporation of zinc within p53 structure is required for p53 folding in a DNA-binding conformation Previous data have shown that chelation of zinc and oxidation of cysteines involved in zinc binding impair p53 DNA-binding and alter the native, wild-type conformation of in vitro-translated p53. These observations are consistent with the structural data showing the presence of zinc within the DNA-binding domain of p53 (Cho et al., 1994; Hainaut and Milner, 1993b) . However, so far it has never been demonstrated that the presence of zinc is required to allow p53 to adopt a DNA-binding conformation. Such a demonstration requires obtaining a form of p53 which does not contain zinc but which has the potential to fold into a DNA-binding conformation upon addition of the metal. We have therefore prepared protein extracts of Sf9 cells with baculovirus-expressed human wild-type p53, in buers containing reducing (5 mM DTT) and chelating (200 mM EDTA) agents. Figure 1a shows that these conditions allowed us to obtain a form of p53 that does not bind constitutively to DNA even in the presence of PAb421, but can be reactivated by addition of ZnCl 2 , showing zinc is required to restore DNA-binding activity. However excess zinc (400 mM) impaired p53 DNA-binding, probably because of disruption of the protein structure. It should be noted that this assay was performed in the presence of EDTA (200 mM), which most probably sequesters at least part of the metal. This may explain why concentrations of ZnCl 2 above physiological levels are needed to restore p53 activity. The eect of ZnCl 2 was inhibited by addition to the reaction of the metal chelators TPEN (4125 mM) or orthophenantroline (4250 mM) (data not shown).
To determine if acquisition of DNA-binding competence induced by zinc was correlated with conformational changes in the protein, recombinant p53 was immunoprecipitated using the conformation-speci®c monoclonal antibodies PAb1620 and PAb240. We observed that zinc induced p53 to fold into the wildtype, PAb1620 + conformation in a concentrationdependent manner (Figure 1b ). In the absence of zinc, the protein was reactive with PAb240 (speci®c for unfolded, mutant-like p53). Addition of zinc induced a partial refolding at 100 mM (50% of the protein is PAb1620 + ) and a total refolding of the protein at 200 mM, a dose at which DNA-binding activity was maximal (see Figure 1a) . In Figure 1b , it also appears that addition of zinc at 200 mM increased the precipitation of p53 with both DO7 (reacting with an epitope in the N-terminus) and PAb421 (reacting with an epitope in the C-terminus). This observation suggests that conformational change induced by the metal increases the accessibility of p53 extremities to antibodies.
To determine if modi®cations in p53 conformation and DNA-binding activity were correlated with zinc incorporation, extracts of Sf9 cells containing wild-type p53 and prepared as described above were incubated with 65 ZnCl 2 (100 mM). The p53 protein was then immunoprecipitated using the monoclonal antibody DO7 and the radioactivity associated with the immunoprecipitates was counted. As controls, similar experiments were done in the absence of recombinant protein or in the presence of both wild-type p53 and TPEN (N, N, N', N'-tetrakis(2-pyrimidylmethylethyl) ethylenediamine), a metal chelator with high anity for transition metals including zinc . Figure 1c shows that addition of 65 ZnCl 2 resulted in incorporation of the metal in p53, which could be prevented by addition of an equimolar amount of TPEN. The eect of TPEN was more marked at 378C than at room temperature, consistent with the idea that temperature increases the¯exibility of p53 and renders the protein more sensitive to chelation (Hainaut et al., 1995a) . Incorporation of radioactive zinc was also prevented by addition of cold ZnCl 2 (data not shown). Overall, these results indicate that the in vitro folding of p53 in a DNA-binding conformation is dependent upon incorporation of zinc within the p53 protein structure.
Physiological amounts of extracellular zinc are required for renaturation of wild-type p53 after metal chelation
The metal chelator TPEN readily penetrates across cell membrane and has been used as a tool to modulate intracellular zinc levels in a number of experimental approaches (Parat et al., , 1999 . In a previous study (Verhaegh et al., 1998) (Verhaegh et al., 1998) .
To formally demonstrate that intracellular zinc was required for p53 renaturation, we have developed a two-step renaturation assay based on the approach described by Verhaegh et al. (1998) . In the ®rst step, sub-con¯uent cells were exposed to TPEN (40 mM) for 2 h. In the second step, the culture medium containing TPEN was removed and replaced by medium with de®ned metallic content, and cells were further cultured for 1 h before extraction of nuclear proteins and analysis of DNA-binding capacity (Figure 2) .
In Figure 2a , exposure of cells to TPEN for 2 h abrogated DNA-binding activity (lane 3). DNAbinding was restored and increased when the medium containing TPEN was replaced by normal medium (lane 4). The extent of increase (threefold) was similar to the one induced by DNA-damaging agents such as hydrogen peroxide (data not shown, see also Verhaegh et al., 1998) . Renaturation was largely prevented when a medium depleted in transition metals (chelex-treated medium) was used instead of normal medium (lane 5). However, supplementation of chelex-treated medium with ZnCl 2 (30 mM) was sucient to restore DNA-binding activity to levels almost identical as with normal medium (lane 9, compare with lane 8). It is important to note that during these experiments the levels of p53 protein increased in cells exposed to TPEN (data not shown). As discussed in a previous paper, we interpret this increase as a result of Recombinant p53 protein was precipitated with monoclonal antibodies PAb240 (speci®c for`mutant', unfolded conformation), PAb1620 (speci®c for`wild-type', folded conformation), DO-7 and PAb421 (which react with both conformers, and that recognize epitopes in the N and C terminus of p53, respectively). PAb416 (speci®c for SV40 LT Ag) was used as a negative control. Immunoprecipitates were analysed by Western blot with the rabbit polyclonal antibody to p53 CM-1. Black arrowheads: p53. A minor, p53-related band is also detected at 42 kDa. Crude extracts containing recombinant protein (Rec) and a mixture of all antibodies used in immunoprecipitation (Mix Ig) were also loaded as positive or negative controls, respectively. (c) Incorporation of radioactive zinc ( 65 Zn) into recombinant p53 and prevention by metal chelation. Immunoprecipitation of recombinant p53 with DO7 antibody was performed after 20 min incubation of Sf9 cell extracts in the presence of 100 mM of 65 ZnCl 2 , at room temperature (RT) or at 378C. The same experiment was also performed in the presence or in the absence of the metal-chelator TPEN (100 mM). Incorporation of 65 Zn was quanti®ed by scintillation counting using a gamma counter. Results are displayed as histograms.`Control' corresponds to 65 Zn incorporated into recombinant p53 and was adjusted to 100% (mean of three dierent experiments).`TPEN' corresponds to the percentage of immunoprecipitated 65 Zn in the presence of the metal chelator (average and standard deviation of three dierent experiments) the increased stability of the protein after removal of zinc (Verhaegh et al., 1998) . The main novel information provided by the experiments reported here is that renaturation of p53 after chelation by TPEN was dependent upon the presence of zinc in the extracellular medium. As controls, cells not exposed to TPEN before medium change exhibited no variation in p53 DNA-binding when cultured in these dierent media. Figure 2b shows that renaturation of p53 DNA-binding was dependent upon the concentration of ZnCl 2 . Together, these results and those in Figure 1 support the hypothesis that zinc plays a role in the control of p53 conformation and DNA-binding competence.
Cadmium competes with zinc for binding to p53 but does not allow p53 renaturation after chelation by TPEN Cadmium is a transition metal chemically close to zinc, which can replace zinc in several protein structures such as zinc ®ngers (Bittel et al., 1998; Freedman et al., 1988; Glusker 1991; Thiesen and Bach, 1991) . We have recently shown that cadmium abrogated p53 DNAbinding by disruption of its wild-type conformation . Figure 3a shows that cadmium competed with zinc for incorporation into p53 when human recombinant p53 was incubated with 100 mM 65 ZnCl 2 and 50 mM CdCl 2 . As observed with TPEN in Figure 1c , the eect of cadmium was temperaturedependent, consistent with the idea that temperature increases the¯exibility of the protein, making it more sensitive to metal substitution.
To determine if cadmium allowed renaturation of p53 in intact cells, we performed a two-step-renaturation assay as described in Figure 2a , using chelextreated medium supplemented with CdCl 2 (30 mM) in the second step of the assay. Figure 3b shows that cadmium did not allow renaturation of p53 DNAbinding after chelation with TPEN (lane 6). Moreover, cadmium abolished p53 DNA-binding in cells not treated with TPEN (lane 3). These results are consistent with previous data showing that cadmium at relatively low doses could perturb p53 folding and DNA-binding activity .
Cobalt, but not other transition metals, allows renaturation of p53 after chelation with TPEN
The two-step-renaturation assay was used to investigate the role of the other transition metals in p53 renaturation after chelation with TPEN. Chelex-treated medium was supplemented with FeCl 2 , CoCl 2 , NiCl 2 or CuSO 4 and used in the second step of the assay as described in Figure 2a . In cells not exposed to TPEN before medium change, none of these metals aected p53 DNA-binding activity (Figure 4) . Restoration of p53 DNA-binding was observed with CoCl 2 , but not with any of the other metals. These data are consistent with previous in vitro observations that Co 2+ could substitute for Zn 2+ in p53 (Hainaut et al., 1995b) . Note that the concentration of CoCl 2 required for renaturation of p53 DNA-binding (125 mM) was higher than that of zinc (5 mM). Cobalt has been shown in vitro to maintain the geometry of tetrahedral metal coordination sites in several zinc-binding proteins (Glusker, 1991) . This is not the case for other metals used in this experiment. These results and those with cadmium indicate that metal size and coordination geometry are essential factors determining the correct orientation and folding of the p53 DNA-binding domain.
Metallothionein modulates p53 conformation, DNA-binding and transcriptional activity
Intracellular levels of zinc and other transition metals are tightly regulated by metallothioneins (MT), a class of small, cysteine-rich proteins that bind up to seven In step I, cells were exposed to the cell permeant metal-chelator TPEN (40 mM), for 2 h and control cells were cultured in the absence of TPEN (N, normal medium containing ubiquitous traces of metals). In step II, culture medium was removed and replaced by media containing dierent levels of metals. In all lanes except lane 3, cells were thus further cultured for 1 h in normal medium (N), transition-metal-free medium (C, medium treated with chelex resin), or chelex-treated medium supplemented with ZnCl 2 at 30 mM (C+Zn). After treatment, cells were harvested and nuclear protein extracts were used to measure p53 DNA-binding activity by EMSA (40 mg protein/binding reaction). Experiments were carried out in the presence of PAb421. A portion of the autoradiogram is shown with DNA:p53:PAb421 complexes (white arrowhead) and a non speci®c band (7), corresponding to complexes of DNA with an unidenti®ed protein (distinct from p53) that binds in a non-sequence speci®c-manner to DNA 16 . (b) Dose-response of p53 renaturation by zinc. Two-step renaturation assay similar to the one described in (a) was performed using chelex-treated medium supplemented with ZnCl 2 at concentrations as indicated. Only the portion of the autoradiogram containing DNA:p53:PAb421 complexes is shown (white arrowheads)
Zinc-dependent folding of p53 C Me Â plan et al equivalents of zinc. MT exist in several isoforms, the most abundant and widely distributed being MTI and MTII (Vallee, 1991) . Thionein, the metal-free form of metallothionein, regulates metal transfer reactions in several metalloproteins and can remove zinc from zinc ®nger transcription factors SP1 and Xenopus TFIIIA, thereby abrogating their transcriptional activity (Zeng et al., 1991a,b) . To determine if thionein could also inactivate p53 DNA-binding, murine p53 translated in vitro was incubated for 20 min at 378C with puri®ed, human recombinant thionein (apo-MTI). Figure 5 shows that thionein (25 mM) induced wild-type p53 to switch to a PAb240 + form, and inhibited binding of p53 to a speci®c consensus sequence in vitro. Supplementation of thionein with equimolar amounts of zinc prior to incubation with p53 abrogated this eect. These results suggest that thionein can inactivate p53 in vitro by sequestration of zinc and dissociation of zinc-p53 complexes.
To determine whether metallothionein may also modulate the activity of p53 in intact cells, we cotransfected a metallothionein expression vector (pBPV-MTIIA) with human wild-type p53 (p53pcDNA) and a p53-dependent reporter gene (pRCGDFoslacZ), into p53-null mouse ®broblasts (Balb/c 10.1). Results show that transfection of the MT vector induced a reproducible and statistically signi®cant threefold increase in p53 transcriptional activity (P50.01) (Figure 6 ). However, when transfected in large excess, MT reduced the transcriptional activity of p53 by an average of 50%. These results suggest that overexpression of MT aects p53 activity in intact cells. When transfected in excess as compared to p53, MT exerts an inhibitory eect consistent with a metal chelator eect of MT. However, when expressed at lower levels, MT may catalyze metaltransfer reactions regulating the folding of the DNAbinding domain of p53, thus enhancing its DNAbinding capacity. In the ®rst step, cells were treated with TPEN (T) or not (N, normal medium). In the second step, the medium was removed and replaced with either normal medium (N, lanes 1 and 4), chelextreated medium supplemented with ZnCl 2 at 30 mM (C+Zn, lanes 2 and 5), or CdCl 2 at 30 mM (C+Cd, lanes 3 and 6). The DNAbinding activity of nuclear protein extracts (40 mg proteins/ binding experiment) was analysed by EMSA. White arrowhead: DNA:p53:PAb421 complexes, (7): non-speci®c band Figure 4 Eects of transition metals on p53 renaturation after chelation with TPEN in intact cells. (a) As control, a two-step renaturation assay was performed as described in legend to Figure  2a . In step II, the culture medium of cells which were cultured in the absence (Without TPEN) or in the presence of TPEN (After TPEN) was replaced by normal (N) or chelex-treated (C) medium. Cells were further cultured for 1 h before harvesting, and nuclear extracts were used to analyse DNA-binding activity of p53. A portion of the autoradiogram with the DNA:p53: PAb421 complexes (white arrowhead) is shown. (b) To test the eect of transition metals, a two-step renaturation assay was performed. Cells were ®rst cultured in the absence (without TPEN) or presence (after TPEN), then, in the second step II, the medium was removed and cells were further cultured for 1 h in chelex-treated medium supplemented with FeCl 2 , CoCl 2 , NiCl 2 or CuSO 4 . Dose-response for each metal was done. FeCl 2 , CoCl 2 or NiCl 2 , were used at 5 mM (lanes 1 and 4), 25 mM (lanes 2 and 5), or 125 mM (lanes 3 and 6), and CuSO 4 was used at 3 mM (lanes 1 and 4), 10 mM (lanes 2 and 5), or 30 mM (lanes 3 and 6). White arrowhead: DNA:p53:PAb421 complexes Oncogene Zinc-dependent folding of p53 C Me Â plan et al
Discussion
Zinc binding by p53 was initially identi®ed on the basis of biochemical evidence and was con®rmed when the partial crystal structure of the protein was published (Cho et al., 1994; Pavletich et al., 1993) . The zinc atom has an essential structural role in stabilizing the architecture of the DNA-binding domain of p53 and it has clearly been shown that zinc is an important cofactor for p53 DNA-binding activity in vitro (Hainaut and Milner, 1993b) . Most of this evidence relies on the fact that metal chelators can remove zinc from p53, turning the protein to a`mutant-like' form with loss of sequence-speci®c DNA-binding activity. However, so far, the reversibility of this phenomenon has never been clearly established. In vitro, metal chelation from p53 results in the rapid oxidation of cysteines and in the formation of disul®de-linked protein aggregates. Thiol reduction solubilizes these complexes but this is not sucient to allow the protein to fold back into`wildtype' conformation, competent for DNA-binding. In this work, we have prepared a form of recombinant p53 lacking zinc, which does not bind DNA with high anity. The conditions for obtaining such a form of the protein included the presence of a chelator (EDTA, 200 mM) to prevent the incoporation of zinc within the protein structure, and of a thiol-reducing agent (DTT, 5 mM) to prevent the formation of disul®des. Upon addition of zinc, this protein switches from the PAb240 + (`mutant') to the PAb1620 + (`wild-type') form and acquires the capacity to bind to DNA with high anity. Experiments with radioactive zinc show that this eect is indeed correlated with incorporation of the metal within the protein structure. Moreover, dose-response experiments indicate that the eects of zinc is biphasic, with ®rst a dose-dependent increase and second, an inhibition in the presence of excess zinc. However, one of the major limits of these in vitro experiments is that the presence of EDTA and DTT do not allow for a precise evaluation of the anity of p53-zinc interactions.
These results provide a clear demonstration that incorporation of zinc induces the folding of p53 into a wild-type, DNA-binding conformation, and are fully consistent with data published by Rainwater et al., (1995) showing that zinc is required for p53 DNA binding. Our results also show that, in a proper redox and metallic environment, wild-type p53 can switch from a PAb240 + to a PAb1620 + conformation. Given the position of the epitope recognized by PAb240 (residues 213 ± 217), this switch corresponds to a major conformational reorganization of the p53 molecule upon addition of zinc. These data contradict earlier assumptions that the PAb240 + state of p53 represents an irreversibly denatured form of the protein (Cho et al., 1994) .
To examine the eects of metals on p53 in the context of living cells, we have taken advantage of an experimental approach previously developed in our laboratory and described in Verhaegh et al. (1998) . In the latter study, it was shown that exposure of MCF-7 to the metal chelator TPEN induces p53 to switch from wild-type' to`mutant' conformation with loss of DNA-binding activity. Removal of the chelator from the culture medium allowed p53 to fold back into wild- CS sequence (a), and p53 conformation was analysed by immunoprecipitation using conformation-sensitive antibodies (b). IVT-p53 protein precipitated with monoclonal antibodies PAb240 (speci®c for mutant', unfolded conformation), PAb1620 and PAb246 (speci®c for`wild-type', folded conformation) and PAb249 (which reacts with both conformers). PAb419 (speci®c for SV40 LT) was used as a negative control. Presence of type conformation, restoring and also increasing DNAbinding. This increase was interpreted as a consequence of p53 stabilization and accumulation during treatment by TPEN, so that when TPEN is removed from the medium cells contain high amounts of p53 that can be converted to`wild-type' conformation (Verhaegh et al., 1998) . This observation forms the basis of the`two-step renaturation assay' described here, in which cells exposed to TPEN in the ®rst step were incubated in media containing de®ned levels of selected metals in the second step. We have shown that addition of extracellular zinc at concentrations as low as 5 mM was sucient to allow the renaturation of wild-type p53. No other metal tested supported p53 renaturation, with the exception of Co 2+ , albeit at concentrations 25 times higher than Zn 2+ . These observations entail three important conclusions. First, extracellular metals are needed for p53 renaturation after chelation, suggesting that the¯uxes of metals may control p53 conformation and activity in intact cells. Second, the concentration of zinc is within the physiological range of intracellular zinc concentrations, which vary between 2 and 200 mM, depending upon cell type (Berg and Shi, 1996; Canzoniero et al., 1997; Cuajungco and Lees 1997; Pattison and Cousins, 1986a,b) . Third, the metals that can participate in p53 renaturation are the same as those that were shown to bind to p53 in vitro and to maintain the tetrahedral geometry of the metal coordination site. The fact that Co 2+ could substitute for zinc (albeit at a higher concentration), is compatible with data on the respective anities of Zn 2+ , and Co 2+ for tetrahedral, cysteine coordination clusters. In contrast, Cd 2+ does not allow p53 renaturation and can even inhibit the renaturation induced by Zn 2+ , consistent with previous studies showing that this metal can inhibit p53 by altering the folding of the DNA-binding domain .
Most of intracellular zinc is immobilized in proteins, in particular in metallothioneins. However, cells also contain a pool of labile zinc, which is in dynamic equilibrium with the extracellular medium. In primary hepatocytes, the size of the labile pool has been evaluated in single cells by epi¯uorescence using the indicator zinquin (ethyl(2-methyl-8-p-toluenesulfonamido-6-quinolyloxy) acetate), and values of 0.61 ± 2.7 (mean 1.27) mM have been obtained (Zalewski et al., 1994 (Zalewski et al., , 1996 . This intracellular pool of labile zinc could undergo important¯uctuations (3 ± 5-fold) depending on the availability of zinc in the extracellular medium (Zalewski et al., 1994 (Zalewski et al., , 1996 . These data indicate that intracellular free zinc is in dynamic equilibrium with the extracellular zinc supply, and that changes in zinc levels in the 1 ± 10 mM range might have a regulatory eect on speci®c, intracellular metalloproteins.
Renaturation into the`wild-type' form has proved extremely dicult to achieve using puri®ed or in vitro translated p53 (Hainaut and Milner, 1992, 1993a) . With temperature-sensitive p53 mutants translated in rabbit reticulocyte lysate, a temperature change from 32 to 378C induced the protein to switch from`wildtype' to`mutant' form within 2 min. However, the conversion back to the`wild-type' form was found to be a slow process, and only partial renaturation was observed after 4 h of incubation back at 328C.
Moreover, renaturation was totally prevented by addition of a non-hydrolysable analog of ATP, suggesting that changing the conformation of p53 from`mutant' to wild-type' is an energy-dependent process (Hainaut and Milner, 1992) . In the present experiments, the observation that p53 fully folds back from`mutant' to`wild-type' form in intact cells within 1 h suggests that cells contain chaperone activities to facilitate metal-dependent changes in p53 conformation.
Recent experimental evidence has led us to hypothesize that metallothioneins may be involved in such a chaperone activity (Jacob et al., 1998; Jiang et al., 1998; Maret et al., 1999) . Metallothioneins contain up to seven zinc atoms per molecule, organized in two clusters of tetrahedral zinc-sulfur bonds. It has been proposed that the main function of metallothioneins is to control zinc distribution as a function of the energy state of the cell. Thionein, the apo-(metal-free) form of MT, is usually not found inside cells but may be transiently generated in vitro by a number of biochemical manipulations. Thionein has been shown to eciently remove zinc from metalloenzymes as well as from transcription factors, suggesting that this protein has the potential to regulate the metal-dependent folding of speci®c metalloproteins (Cano-Gauci and Sarkar, 1996; Roesijadi et al., 1998; Zeng et al., 1991a) . In a recent study, thionein was found to rapidly activate a group of enzymes in which zinc is bound at an inhibitory site (Maret et al., 1999) . This reaction was selective, since thionein did not remove zinc from the catalytic sites of zinc metalloenzymes.
To test the hypothesis that thionein could act as a chelating agent to remove zinc from p53, we have incubated in vitro translated, wild-type p53 with recombinant thionein. Our results show that addition of thionein at at 25 mM induced the disruption of wild-type' p53, with loss of DNA-binding activity, in a manner that was prevented by addition of ZnCl 2 . After co-transfection of metallothionein with wild-type p53 and a p53-dependent reporter gene, metallothionein was found to modulate p53 transcriptional activity. Overall, our data suggest that metallothionein might act as a regulator of p53 folding and activity. This regulatory activity is reminiscent of the one exerted by another redox-active protein, Thioredoxin (Trx) (Ueno et al., 1999) . Indeed, both TRX and MT are known to cooperate within the same pathways of redox regulation of proteins (Jacob et al., 1998) . Taken together, these results suggest that MT may play a subtle role in the control of p53. Interestingly, MT plays a similar role as a metal chaperone in the control of the DNA-binding by NF-kB, a transcription factor which shows many regulatory similarities to p53 including redox-sensitive cysteines in the DNAbinding domain, but does not contain structural zinc (Abdel-Mageed and Agrawal, 1998) Sakurai et al., 1999) . Indeed, the role of MT in the control of p53 function is likely be complex since metal movements may be accompanied by concomitant redox changes in thiols which are involved in metal transfer reactions.
Changes in intracellular MT levels have been implicated in a number of biological processes, including cell proliferation, apoptosis and dierentia-tion. Elevated levels of MT are found in rapidly growing tissues such as neonatal liver and various types of human tumors, suggesting a role for MT in the regulation of cell proliferation (Tsujikawa et al., 1994; Wlostowski, 1993) . Cell-cycle analysis has shown that levels of both nuclear and cytoplasmic MT oscillate during cell-cycle, reaching a maximum in late G1 phase and at the G1/S transition (Nagel and Vallee, 1995) . In a recent study, a role for zinc mediated by MT has been postulated in the process of dierentiation of 3T3L1 mouse ®broblasts to adipocytes (Schmidt and Beyersmann, 1999) . Twenty-four hours after stimulation of dierentiation by hormones, these cells enter a phase of synchronous proliferation during which the cellular contents in zinc and MT rise rapidly by ®vefold and threefold levels, respectively. Simultaneously, MT is translocated from the cytoplasm to the nucleus. Deprivation of zinc with TPEN inhibits the proliferative phase. This short proliferative phase is followed by a slower stage of dierentiation to adipocytes during which the levels of MT and zinc decline quickly to basal levels, with redistribution of MT to the cytoplasm. These observations could be interpreted to mean that MT accumulation in the nucleus may contribute to inactivate transcriptional suppressors during the proliferative stage.
The above observations suggest that a rise in nuclear MT is an important feature in cell proliferation. The understanding of how MT, zinc and p53 cooperate in the regulation of these important physiological processes awaits further experimental evaluation.
Materials and methods

Production of wild-type human recombinant p53
Wild-type human recombinant p53 was produced in Sf9 infected cells using a baculovirus expression system (Quantum Bioprobe). Total protein extracts from Sf9 cells were prepared as follows: infected cells were lysed in buer A (20 mM HEPES [pH 7.6], 20% glycerol, 140 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 5 mM dithiothreitol [DTT], 0.1% Nonidet P40) in the presence of a cocktail of protease inhibitors: 0.5 mg/ml Leupeptin, 0.5 mM PMSF, 2 mg/ml Aprotinin, 0.7 mg/ml Pepstatin (all from Sigma). After 4 min of centrifugation at 400 g at 48C, supernatants containing total protein extracts were aliquoted and stored at 7808C. Protein contents were quanti®ed by the Lowry method and estimated to be 5.3 mg/ml. Twenty-®ve mg of protein extracts were diluted ®vefold in buer A containing either cold ZnCl 2 (Sigma) or 65 ZnCl 2 (0.1 ± 2.5 mCi/mg zinc, product code ZAS1, Amersham), plus CdCl 2 or TPEN (all from Sigma) as indicated, and incubated for 20 min at 378C under an atmosphere saturated with argon, before DNA-binding or immunoprecipitation was performed. All experiments were carried out under oxygen-free, argon-saturated atmosphere to minimize thiol oxidation.
Cell culture
The human breast carcinoma cell line MCF7, expressing high levels of wild-type p53, was cultured at 378C under 10% CO 2 in Dulbecco's Modi®ed Eagle's Medium (DMEM, Gibco BRL), supplemented with 10% fetal calf serum (FCS, PAA), 2 mM L-glutamine and antibiotics. Murine 10.1 ®broblasts (p53-de®cient) were cultured at 378C under 5% CO 2 in DMEM supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine and antibiotics (Lassus et al., 1996) .
Two-step renaturation assay
This assay is derived from the one described by Verhaegh et al. (1998) to analyse the eects of metal chelation on p53 protein conformation and activity in intact cells (Verhaegh et al., 1998) . In the ®rst step, MCF7 cells at 70 ± 80% con¯uence were exposed for 2 h to 40 mM TPEN (N, N, N', N'-tetrakis (2-pyridylmethyl)ethylenediamine). In the second step, the culture medium containing TPEN was removed and replaced by either of the following media: (1) DMEM (containing ubiquitous metals); (2) transition metal-free medium (DMEM without serum and treated for 2 h with Chelex 100-chelating resin to remove traces of transition metals); or (3) transition metal-free medium supplemented with metals (either ZnCl 2 , CdCl 2 , CoCl 2 , CuSO 4 , NiCl 2 or FeCl 2 ). Cells were further cultured for 1 h before protein extraction. Stock solutions of transition metals were prepared in 10 mM Tris pH 7.4. All chemicals were from Sigma.
Cytoplasmic and nuclear protein extractions
Control and treated cells were washed in PBS and collected by scraping. Cytoplasmic and nuclear extracts were prepared as previously described (Gottlieb et al., 1998) . Cells were lysed in buer B (same as buer A but with 10 mM instead of 140 mM NaCl and 1 mM instead of 5 mM DTT). After centrifugation, supernatants were kept as cytoplasmic extracts and nuclear protein extracts were prepared by extraction of the pellet in buer C (same as buer B but with 0.5 mM instead of 10 mM NaCl) in the presence of a cocktail of protease inhibitors as described above.
Electro-Mobility-Shift Assay (EMSA)
The protocol used for EMSA was described previously Verhaegh et al., 1997 Verhaegh et al., , 1998 ) and modi®ed as follows: the double-stranded p53 consensusbinding sequences p53
CS
(5'-GGACATGCCCGGG-CATGTCC-3') (Funk et al., 1992) was end-labeled with 3000 Ci/mmol g 32 P-ATP (Amersham, UK). DNA-binding experiments were performed for 30 min at room temperature. Total protein extracts of Sf9 cells containing human recombinant p53 (25 mg protein/reaction) were incubated with 0.7 ng of end-labeled p53 CS in buer A in the presence of 7 mg bovine serum albumin (BSA) and 3.1 mg herring sperm (HS) DNA, as non-speci®c competitor (Promega). Experiments included the monoclonal antibody PAb421 (500 ng) (500 ng) (OP03, Oncogene Science), that stabilizes and supershifts p53-DNA complexes. DNA-binding assays using MCF7 nuclear extracts (40 mg protein/reaction) were performed using a similar protocol with the following modi®cations: binding reaction was performed in the presence of 0.5 ng of labeled p53 CS , 5 mg of BSA, 2.2 mg HS DNA and 100 ng PAb421. After incubation, DNA: p53: PAb421 complexes were resolved on a 4% non-denaturating PAGE in 16TBE for 2 ± 3 h at 120 V. Gels were then ®xed, dried and exposed to Kodak X-ray ®lms at 7808C. Control experiments using a DNA sequence non-speci®c for p53, as well as competition experiments using unlabeled p53
, were performed to demonstrate the speci®city of binding (data not shown).
Conformation-specific immunoprecipitation of p53
Cell extracts (50 mg protein) containing recombinant human p53, incubated with metals and chelator in conditions as described above, were diluted (20 times) in immunoprecipitation (IP) buer (5 mM DTT, 0.2 mM EDTA, 10 mM Tris HCl pH 7.6, 140 mM NaCl, 0.5% NP40, plus proteinase inhibitors as above). Extracts were pre-cleared by incubation with PAb416 antibody (speci®c for large T Antigen of SV40, DP29, Oncogene Science) for 15 min at 48C with shaking. The non-speci®c antibody-protein complexes were removed by incubation with 20% (vol/vol) precipitating matrix, corresponding to goat anti-mouse immunoglobulin G (1 mg, Pierce) coupled to Protein A sepharose (CL-4B, Sigma), for 15 min at 48C with shaking, and followed by 5 min centrifugation (15 000 g) at 48C. Supernatants were aliquoted for immunoprecipitation with 1 mg of monoclonal antibodies to p53. PAb1620 (speci®c for`wild-type' form of p53) and PAb240 (speci®c for`mutant' form of p53) were used to determine the conformation of the protein. DO7 (Dako) and PAb421 that recognize both`wild-type' and`mutant' conformers were used as positive controls. Immune complexes were collected with 20% (vol/vol) precipitating matrix and washed ®ve times in IP buer. For conformation analysis, precipitates were denatured in Laemmli buer, resolved in 10% SDS ± PAGE, electrotransferred to PVDF membranes (Boehringer) and immunoblotted with the rabbit polyclonal anti-p53 antibody CM-1 (1 : 1000 Novocastra). Peroxidase-conjugated goat anti-rabbit immunoglobulin G (250 ng/ml, Pierce) was used as the secondary antibody, followed by enhanced chemiluminescence using CovaLab detection kit as speci®ed by the manufacturer (Dako). For the measure of incorporation of 65 Zn in p53, immunoprecipitates were resuspended in scintillation buer and the amount of 65 Zn was quanti®ed using a gamma counter with a counting window at 750 ± 1000 keV. In the case of immunoprecipitation of murine in vitro-translated p53, wild-type' p53 conformers were precipitated with PAb1620 or PAb246, and`mutant' conformers were precipitated with PAb240. PAb248, that recognizes both conformers, was used as positive control, and PAb419 (anti-SV40 LT Ag) was used as negative control.
Transfections and b-galactosidase assays
Murine 10.1 ®broblasts were co-transfected by the calcium phosphate method with pRGCDFosLacZ reporter plasmid (5 mg), containing the p53 binding site located in the Ribosomal Gene Cluster (RGC-bgal) (Frebourg et al., 1992) , p53pcDNA (1 mg) expressing full-length human p53 under a CMV promoter, and BPV-MTIIA plasmid (1 or 10 mg) expressing human metallothionein-IIA under its own promoter (Karin et al., 1983) . Transfection eciency to be 50 ± 70% with a vector expressing the green¯uorescent protein (pEGFP-C1) under the same conditions (Clontech). Medium was changed 14 h later and cells were further cultured for 8 h. Cytoplasmic protein extracts (100 mg) of transfected cells were used to perform b-galactosidase assays, and nuclear extracts were used to determine p53 levels by immunoblotting with DO7 antibody. Goat anti-mouse immunoglobulin G (250 ng/ml, Pierce) was used as the secondary antibody, followed by detection using the CovaLab kit (Dako).
Exposure of wild-type, in vitro translated murine p53 to recombinant human thionein (apo-MT-I)
Wild-type murine p53 (plasmid pSP6p53 ala135 ) was translated in vitro in rabbit reticulocyte lysate (Promega) containing 0.75 mM of 35 S-methionine (Milner and Medcalf, 1991) . The amount of p53 generated was approximately 15 ± 30 ng/mg lysate protein. After 1 h, translation was blocked with anisomycin (2 mg/ml) and aliquots of lysate were exposed for 20 min to human recombinant thionein (apo-MT I) at a ®nal concentration of 2 ± 25 mM. These concentrations are within the range of intracellular levels of MT after exposure of cells to divalent metals. Preparation of recombinant thionein is described in (Kille et al., 1991) . Thionein was kept at 7808C as a 11 mM solution in 0.02 M HCl and was diluted immediately before use in 10 mM Tris-HCl (pH 8), 140 mM NaCl, 2 mM DTT, under argon-saturated atmosphere. In control experiments, thionein was converted to MT by addition of seven equivalents of ZnCl 2 before incubation with p53. Protein conformation was analysed by immunoprecipitation and DNA-binding activity by EMSA, using the p53 CS probe as described (Hainaut and Milner, 1993a) .
